High Density Lipoprotein and Its Precursor Protein Apolipoprotein A1 as Potential Therapeutics to Prevent Anthracycline Associated Cardiotoxicity

George E. G. Kluck, Kristina K. Durham, Jeong-Ah Yoo, Bernardo L. Trigatti

Open source

DOI
10.3389/fcvm.2020.00065
Published
2020-04-28
Container
Frontiers in Cardiovascular Medicine
Publisher
Frontiers Media SA
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fcvm.2020.00065,
  title = {High Density Lipoprotein and Its Precursor Protein Apolipoprotein A1 as Potential Therapeutics to Prevent Anthracycline Associated Cardiotoxicity},
  author = {George E. G. Kluck and Kristina K. Durham and Jeong-Ah Yoo and Bernardo L. Trigatti},
  year = {2020},
  journal = {Frontiers in Cardiovascular Medicine},
  doi = {10.3389/fcvm.2020.00065},
  url = {https://doi.org/10.3389/fcvm.2020.00065}
}

RIS

TY  - JOUR
TI  - High Density Lipoprotein and Its Precursor Protein Apolipoprotein A1 as Potential Therapeutics to Prevent Anthracycline Associated Cardiotoxicity
AU  - George E. G. Kluck
AU  - Kristina K. Durham
AU  - Jeong-Ah Yoo
AU  - Bernardo L. Trigatti
PY  - 2020
JO  - Frontiers in Cardiovascular Medicine
DO  - 10.3389/fcvm.2020.00065
UR  - https://doi.org/10.3389/fcvm.2020.00065
ER  - 

APA

Kluck, G. E. G., Durham, K. K., Yoo, J., & Trigatti, B. L. (2020). High Density Lipoprotein and Its Precursor Protein Apolipoprotein A1 as Potential Therapeutics to Prevent Anthracycline Associated Cardiotoxicity. Frontiers in Cardiovascular Medicine. https://doi.org/10.3389/fcvm.2020.00065

Source records